Parkinson's Disease Trial, Recruiting NCT06080659 Sponsor: Rennes University Hospital Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT06080659
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You speak French as your first language
  • You are right-handed
  • You have completed at least a primary school level of education
  • You do not have any medical or psychiatric condition that could affect your thinking or memory (aside from the condition being studied, if you are a patient)
  • You are registered with a social security scheme
  • You have been fully informed about the study and have signed a consent form agreeing to take part
  • (For one specific group) You have been told by a doctor that you experience noticeable changes in your memory or thinking, meeting specific "subjective cognitive decline-plus" criteria (confirm with trial site)
  • (For one specific group) You have a diagnosis of mild memory or thinking difficulties linked to early Alzheimer's disease, based on specific diagnostic criteria (confirm with trial site)
  • (For one specific group) You have recently been diagnosed with Parkinson's disease and do not currently have any thinking or memory problems (confirm with trial site)
  • (For one specific group) You have Parkinson's disease along with mild thinking or memory difficulties, based on specific diagnostic criteria (confirm with trial site)

Who may not be able to join:

  • You have a pacemaker, defibrillator, cochlear implant, neurosurgical clips, nerve stimulator, or any metal objects in or around your eyes or brain that would make an MRI scan unsafe
  • You have had a new internal prosthesis fitted in the last 4 weeks, or a bone-fixing device fitted in the last 6 weeks
  • Your body measurements mean you cannot safely fit inside an MRI scanner (confirm with trial site)
  • You experience claustrophobia (fear of enclosed spaces)
  • You are pregnant or breastfeeding
  • You are under any form of legal protection, such as guardianship or curatorship, or you are not free to make your own decisions
  • (Patients only) You have a score above 2 on a specific scale used to assess blood vessel-related memory problems (confirm with trial site)
  • (Patients only) You have been diagnosed with dementia based on specific medical criteria (confirm with trial site)
  • (Patients only) You have a sensory problem (such as significant hearing or vision loss) that would interfere with the study tests
  • (Healthy volunteers only) You show signs of cognitive impairment based on a standard memory and thinking test (a score below 26 on the MoCA test)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Pierre-Yves JONIN, PhD, Rennes University Hospital

Phone: 299282555

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Rennes University Hospital
Registry
ClinicalTrials.gov
Start date
6 November 2023
Est. completion
1 November 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Multimodal connectivity graph metrics across diseases

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov